Procedures for the GMP-Compliant Production and Quality Control of [18F]PSMA-1007: A Next Generation Radiofluorinated Tracer for the Detection of Prostate Cancer

Procedures for the GMP-Compliant Production and Quality Control of [18F]PSMA-1007: A Next Generation Radiofluorinated Tracer for the Detection of Prostate Cancer

Radiolabeled tracers targeting the prostate-specific membrane antigen (PSMA) have become important radiopharmaceuticals for the PET-imaging of prostate cancer. In this connection, we recently developed the fluorine-18-labelled PSMA-ligand [18F]PSMA-1007 as the next generation radiofluorinated Glu-ur...

Full description

Bibliographic Details
Main Authors: Jens Cardinale, René Martin, Yvonne Remde, Martin Schäfer, Antje Hienzsch, Sandra Hübner, Anna-Maria Zerges, Heike Marx, Ronny Hesse, Klaus Weber, Rene Smits, Alexander Hoepping, Marco Müller, Oliver C. Neels, Klaus Kopka
Format: Article
Language:English
Published: MDPI AG 2017-09-01
Series:Pharmaceuticals
Subjects:
[18F]PSMA-1007
fluorine-18
PSMA
automation
prostate cancer
PET
Online Access:https://www.mdpi.com/1424-8247/10/4/77

Internet

https://www.mdpi.com/1424-8247/10/4/77

Similar Items